Conditional Cre Activity Specifically in Eythroid Cells

TECHNOLOGY NUMBER: 2022-009
Technology No. 2022-009
MOUSE
1

INNOVATION

Gata1creERT2 BAC transgenic mice express erythroid lineage-specific, tamoxifen (Tx)-inducible cre recombinase from the mouse Gata1 (GATA binding protein 1) promoter in adult red blood cells.


ADDITIONAL DETAILS

Jackson https://www.jax.org/strain/036482
  • swap_vertical_circlemode_editInventor (1)
    Lei Yu
  • swap_vertical_circlecloud_downloadSupporting documents (1)
    Product brochure
    Conditional Cre Activity Specifically in Eythroid Cells.pdf
    DOWNLOAD
Questions about this technology?
Contact us